Alflutinib

立即咨询

Alflutinib

本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。

CAS NO:

1869057-83-9

Furmonertinib
AST2818

Alflutinib is a potent inhibitor ofEGFR. Alflutinib inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Alflutinib has the potential for the research of cancer diseases, especially non-small cell lung cancer (NSCLC).

生物活性

Alflutinib is a potent inhibitor ofEGFR. Alflutinib inhibitsEGFRactive mutations as well as the T790M acquired resistant mutation. Alflutinib has the potential for the research ofcancerdiseases, especially non-small cell lungcancer(NSCLC)^[1].

IC₅₀& Target^[1]

EGFR

体外研究
(In Vitro)

AST2818 is designed to inhibit EGFR active mutations as well as the T790M acquired resistant mutation^[1].

Clinical Trial

分子量

568.59

Formula

C₂₈H₃₁F₃N₈O₂

CAS 号

1869057-83-9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.